ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 244 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $715,453 | -8.7% | 27,528 | +0.4% | 0.01% | 0.0% |
| Q1 2024 | $783,840 | +8.3% | 27,407 | +15.9% | 0.01% | 0.0% |
| Q4 2023 | $723,782 | +24.1% | 23,653 | +9.0% | 0.01% | 0.0% |
| Q3 2023 | $583,267 | -68.3% | 21,707 | -58.0% | 0.01% | -64.3% |
| Q2 2023 | $1,842,695 | +48.7% | 51,674 | +5.9% | 0.01% | +27.3% |
| Q1 2023 | $1,239,088 | +64068.2% | 48,783 | +2.4% | 0.01% | -31.2% |
| Q4 2022 | $1,931 | -99.9% | 47,617 | +13.5% | 0.02% | +14.3% |
| Q3 2022 | $1,387,000 | -5.9% | 41,967 | +0.3% | 0.01% | -12.5% |
| Q2 2022 | $1,474,000 | -17.1% | 41,859 | +8.3% | 0.02% | -11.1% |
| Q1 2022 | $1,778,000 | -22.4% | 38,650 | +11.8% | 0.02% | -25.0% |
| Q4 2021 | $2,292,000 | +6.6% | 34,567 | +0.4% | 0.02% | -4.0% |
| Q3 2021 | $2,150,000 | -25.1% | 34,444 | -0.7% | 0.02% | -21.9% |
| Q2 2021 | $2,872,000 | +25.1% | 34,675 | +0.1% | 0.03% | +14.3% |
| Q1 2021 | $2,296,000 | -12.8% | 34,626 | +0.9% | 0.03% | -24.3% |
| Q4 2020 | $2,633,000 | +86.5% | 34,314 | +4.7% | 0.04% | +32.1% |
| Q3 2020 | $1,412,000 | +51.8% | 32,785 | +52.3% | 0.03% | +64.7% |
| Q2 2020 | $930,000 | +37.2% | 21,531 | -8.6% | 0.02% | +13.3% |
| Q1 2020 | $678,000 | -39.5% | 23,551 | +33.4% | 0.02% | -25.0% |
| Q4 2019 | $1,120,000 | +22.9% | 17,657 | -45.4% | 0.02% | +25.0% |
| Q3 2019 | $911,000 | +5.8% | 32,325 | -0.5% | 0.02% | +6.7% |
| Q2 2019 | $861,000 | – | 32,473 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $93,815,000 | 51.06% |
| Aquilo Capital Management, LLC | 436,514 | $12,559,000 | 4.90% |
| Vivo Capital, LLC | 768,674 | $22,115,000 | 2.00% |
| ACUTA CAPITAL PARTNERS, LLC | 109,700 | $3,156,000 | 1.53% |
| Prosight Management, LP | 104,737 | $3,013,000 | 1.41% |
| Capital Impact Advisors, LLC | 84,537 | $2,432,000 | 1.02% |
| Artal Group S.A. | 600,000 | $17,262,000 | 0.73% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 62,000 | $1,784,000 | 0.48% |
| Quantitative Investment Management, LLC | 150,401 | $4,327,000 | 0.47% |
| OAK RIDGE INVESTMENTS LLC | 131,502 | $3,784,000 | 0.39% |